Landos Biopharma, Inc. Debt to Equity Ratio 2021-2024 | LABP
Current and historical debt to equity ratio values for Landos Biopharma, Inc. (LABP) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Landos Biopharma, Inc. debt/equity for the three months ending March 31, 2024 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-03-31 | $0.01B | $0.02B | 0.29 |
| 2023-12-31 | $0.01B | $0.03B | 0.20 |
| 2023-09-30 | $0.01B | $0.04B | 0.15 |
| 2023-06-30 | $0.00B | $0.04B | 0.07 |
| 2023-03-31 | $0.00B | $0.05B | 0.09 |
| 2022-12-31 | $0.01B | $0.04B | 0.16 |
| 2022-09-30 | $0.01B | $0.04B | 0.12 |
| 2022-06-30 | $0.01B | $0.05B | 0.13 |
| 2022-03-31 | $0.02B | $0.06B | 0.25 |
| 2021-12-31 | $0.02B | $0.08B | 0.22 |
| 2021-09-30 | $0.01B | $0.09B | 0.12 |
| 2021-06-30 | $0.01B | $0.11B | 0.12 |
| 2021-03-31 | $0.01B | $0.10B | 0.09 |
| 2020-12-31 | $0.08B | $-0.05B | -1.56 |
| 2020-09-30 | $0.00B | 0.00 | |
| 2020-06-30 | $0.00B | 0.00 | |
| 2020-03-31 | $0.00B | 0.00 | |
